[1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate

C22H19F2N7O3 — CID 118697530

IUPAC[1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate
SMILESO=COC1CNCCN1c1nc(-c2cc(-c3ccon3)n(Cc3ccccc3F)n2)ncc1F
InChIInChI=1S/C22H19F2N7O3/c23-15-4-2-1-3-14(15)12-31-19(17-5-8-34-29-17)9-18(28-31)21-26-10-16(24)22(27-21)30-7-6-25-11-20(30)33-13-32/h1-5,8-10,13,20,25H,6-7,11-12H2
InChIKeyAQOQHNXSBZYQBX-UHFFFAOYSA-N
MW467.44 g/mol
LogP2.23
Rot. Bonds7

About [1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate

[1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate (PubChem CID 118697530) has the molecular formula C22H19F2N7O3 and a molecular weight of 467.44 g/mol. Its IUPAC name is [1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate.

Molecular Properties

Compound Name[1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate
PubChem CID118697530
Molecular FormulaC22H19F2N7O3
Molecular Weight467.44 g/mol
Exact Mass467.15
IUPAC Name[1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate
SMILESO=COC1CNCCN1c1nc(-c2cc(-c3ccon3)n(Cc3ccccc3F)n2)ncc1F
InChIInChI=1S/C22H19F2N7O3/c23-15-4-2-1-3-14(15)12-31-19(17-5-8-34-29-17)9-18(28-31)21-26-10-16(24)22(27-21)30-7-6-25-11-20(30)33-13-32/h1-5,8-10,13,20,25H,6-7,11-12H2
InChIKeyAQOQHNXSBZYQBX-UHFFFAOYSA-N
XLogP2.23
TPSA111.20 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds7
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500467.44
LogP ≤ 52.23
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze [1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate?
The IUPAC name of [1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate (CID 118697530) is [1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate.
What is the SMILES notation for [1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate?
The canonical SMILES for [1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate is O=COC1CNCCN1c1nc(-c2cc(-c3ccon3)n(Cc3ccccc3F)n2)ncc1F.
What is the InChIKey of [1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate?
The InChIKey is AQOQHNXSBZYQBX-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H19F2N7O3/c23-15-4-2-1-3-14(15)12-31-19(17-5-8-34-29-17)9-18(28-31)21-26-10-16(24)22(27-21)30-7-6-25-11-20(30)33-13-32/h1-5,8-10,13,20,25H,6-7,11-12H2.
What are the key properties of [1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate?
[1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate has a molecular weight of 467.44 g/mol, XLogP of 2.23, 7 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]piperazin-2-yl] formate is sourced from PubChem (CID 118697530), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).